Company · CIK 1836056

# Ambrx Biopharma Cayman, Inc.

| CIK | [1836056](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001836056) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | E9 |
| Business address | CA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2022-04-26 |

## Offerings

 3 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-271008 | Shelf Effective | 2023-03-30 | 2023-05-25 | 3 |
| 333-266404 | Shelf Effective | 2022-07-29 | 2022-08-05 | 3 |
| 333-256639 | IPO Final prospectus | 2021-05-28 | 2021-06-21 | 4 |

## Filings

 12

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2023-05-25 | [424B5](https://www.sec.gov/Archives/edgar/data/1836056/000119312523154202/0001193125-23-154202-index.htm) Shelf takedown | 333-271008 | 0001193125-23-154202 |
| 2023-05-02 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1836056/999999999523001234/9999999995-23-001234-index.htm) Declared effective | 333-271008 | 9999999995-23-001234 |
| 2023-03-30 | [S-3](https://www.sec.gov/Archives/edgar/data/1836056/000119312523085776/0001193125-23-085776-index.htm) Shelf registered | 333-271008 | 0001193125-23-085776 |
| 2022-08-05 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1836056/999999999522002279/9999999995-22-002279-index.htm) Declared effective | 333-266404 | 9999999995-22-002279 |
| 2022-08-05 | [424B5](https://www.sec.gov/Archives/edgar/data/1836056/000119312522213604/0001193125-22-213604-index.htm) Shelf takedown | 333-266404 | 0001193125-22-213604 |
| 2022-07-29 | [F-3](https://www.sec.gov/Archives/edgar/data/1836056/000119312522206626/0001193125-22-206626-index.htm) Shelf registered | 333-266404 | 0001193125-22-206626 |
| 2021-06-21 | [424B4](https://www.sec.gov/Archives/edgar/data/1836056/000119312521194058/0001193125-21-194058-index.htm) Final prospectus | 333-256639 | 0001193125-21-194058 |
| 2021-06-17 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1836056/999999999521002400/9999999995-21-002400-index.htm) Declared effective | 333-256765 | 9999999995-21-002400 |
| 2021-06-17 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1836056/999999999521002396/9999999995-21-002396-index.htm) Declared effective | 333-256639 | 9999999995-21-002396 |
| 2021-06-14 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1836056/000119312521189441/0001193125-21-189441-index.htm) Amendment | 333-256639 | 0001193125-21-189441 |
| 2021-05-28 | [F-1](https://www.sec.gov/Archives/edgar/data/1836056/000119312521177104/0001193125-21-177104-index.htm) Registration filed | 333-256639 | 0001193125-21-177104 |
| 2021-02-03 | [DRS](https://www.sec.gov/Archives/edgar/data/1836056/000095012321000963/0000950123-21-000963-index.htm) Draft made public | 377-04163 | 0000950123-21-000963 |

[All filings of this company](https://equitycapital.markets/filings?cik=1836056) · [CSV](https://equitycapital.markets/filings.csv?cik=1836056)

---
Source page: https://equitycapital.markets/company/1836056 · Data: U.S. SEC EDGAR · CC BY 4.0